SelinSomersan-KarakayaMD

Mycobacterial Disease

Instructor in Medicine

Dr. Somersan-Karakaya is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
525 E 68th St # M-528
Box 130
New York, NY 10065
Phone+1 212-746-4749

Fax+1 212-746-6692

New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2009 - 2013
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2006 - 2009
Harvard Medical SchoolClass of 2006

PubMed

29 citations
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, Jason C Wells, Shazia Ali
The Journal of Infectious Diseases. 2022-12-28
62 citations
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis
Thulasi Warrier, Kanishk Kapilashrami, Argyrides Argyrou, Thomas R. Ioerger, David Little
Proceedings of the National Academy of Sciences of the United States of America. 2016-08-02
61 citations
Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations.
Kohta Saito, Thulasi Warrier, Selin Somersan-Karakaya, Lina Kaminski, Jianjie Mi
Proceedings of the National Academy of Sciences of the United States of America. 2017-05-30